BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 20, 2006
View Archived Issues
MPC-7869 studied for drug interaction potential, efficacy in Alzheimer's disease
Read More
MK-677 does not affect Alzheimer's disease progression
Read More
Sipuleucel-T improves survival in hormone refractory prostate cancer
Read More
Acenta and PsychoGenics form psychiatric and neurological disorders collaboration
Read More
Alnylam and Inex advance collaboration on systemic delivery of RNAi therapeutics
Read More
Alnylam and UT Southwestern to develop RNAi therapeutics for high cholesterol
Read More
Transition Therapeutics and Novo Nordisk amend I.N.T. license agreement
Read More
Rivastigmine transdermal patch compares well with capsules
Read More
Tigris licenses anticancer compound from NIH
Read More
Astellas discontinues development of FK-962 for Alzheimer's disease
Read More
Cangene's NDA for rhGH Accretropin accepted for review
Read More
AstraZeneca files NDA for Seroquel SR
Read More
Topical antiinfective REP-8839 begins phase I testing
Read More
Starpharma cleared to study SPL-7013 gel for genital herpes prevention
Read More
Roche exercises option to Ipsen's antidiabetic drug BIM-51077
Read More
U.K. clearance for phase II study of Reolysin with low-dose radiation
Read More
Expanded multiple dose phase I trial of CG-0070 in recurrent bladder cancer
Read More
Theravance and Astellas add Japan to telavancin collaboration
Read More
Mycophenolate mofetil approved in Malaysia for lupus nephritis
Read More
Solvay seeks E.U. approval of Synordia
Read More
Frova filed for prevention of menstrual migraine
Read More
Calpain inhibitor and antioxidant BN-82270 protects from and helps recover hearing loss
Read More
First U.S. clinical data on huperzine A, a Chinese herbal medicine for AD
Read More
Promising preclinical data on novel classes of compounds developed at Enkam
Read More
Recent patents disclose novel antiinfective agents
Read More
Recent ViroChem patent reports novel HIV integrase inhibitors
Read More
Recent Novartis and Devgen patents describe new treatments for cardiovascular diseases
Read More